Acute Liver Failure

Chapter 59


Acute Liver Failure image



In acute liver failure (ALF) there is rapid deterioration of liver function in a previously healthy individual. By definition there is evidence of coagulopathy (International normalized ratio, INR ≥ 1.5) and mental status alteration (encephalopathy) in a patient without preexisting cirrhosis within 26 weeks of the onset of jaundice. ALF has been subdivided into hyperacute (illness < 7 days), acute (illness between 7 to 21 days), and subacute (illness between 21 days and 26 weeks), but these subdivisions have not shown any prognostic significance distinct from the etiology of the liver failure.


The presentation of ALF is rapid, dramatic, and frequently leads to coma and death from cerebral edema and multiorgan failure over the course of a few days. There are approximately 2000 cases of ALF in the United States on a yearly basis. It is a rare indication for liver transplantation, accounting for only 6% of all liver transplants. One-year survival after liver transplantation is 82%, which is lower than the 88% 1-year survival rate seen in all other recipients, probably owing to the higher severity of illness at the time of transplant. Once listed for a liver transplant, patients will wait an average of 3.5 days and 22% of patients will die waiting for a transplant. With only medical management in an intensive care unit (ICU) there is a 25% to 43% transplant-free and spontaneous recovery rate. For this reason, when there is concern for ALF, patients should be immediately transferred to a transplant center where an evaluation for a transplant can begin.



Etiology of Acute Liver Failure


The prognosis of ALF is dependent on its etiology, so every effort should be made to look for the underlying cause of the liver injury (Table 59.1). However, up to 20% of cases will have no discernable cause. The most common cause of ALF in the United States is acetaminophen toxicity, most recently accounting for approximately 39% to 50% of all cases of ALF. Idiosyncratic drug reactions account for 13% of cases of ALF. Viral hepatitis (acute hepatitis A and B combined) has become a less frequent cause of ALF in the United States, accounting for only 12% of all cases. Acute hepatitis C does not appear to lead to ALF. Hepatitis E is a significant cause of liver failure in endemic countries (Russia, Pakistan, Mexico, and India) and should be considered in any patient who travels to these countries and in any pregnant woman, as hepatitis E has a more severe course during pregnancy.



Wilson disease and autoimmune hepatitis account for 3% and 4% of all cases of ALF, respectively, and are unique in that patients can still be considered as having ALF even though there is a preexisting chronic liver disease if the disease previously had been unrecognized. Mushroom toxicity (usually Amanita phalloides) may cause ALF, and the initial history should always include recent mushroom ingestion. Acute fatty liver of pregnancy and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome (Chapter 72) typically occur during the third trimester, and prompt delivery of the fetus is essential to achieve good outcomes.



Diagnosis and Initial Evaluation


All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have a prothrombin time measured and be assessed for subtle alterations in mentation. An INR ≥ 1.5 and evidence of encephalopathy mandate a hospital admission, preferably to an ICU given the potential for rapid clinical deterioration.


History taking should include a careful review of possible medication overdoses (especially acetaminophen and acetaminophen-containing products), medications newly started within the last 6 months, toxins (Amanita phalloides mushrooms in particular), herbal supplements, and risk factors for exposure to an acute viral hepatitis. Physical examination should focus on any stigmata of chronic liver disease; the prognosis is improved in a patient with acute on chronic liver injury compared to a patient with ALF alone. Observe patients frequently for the development of hepatic encephalopathy; once grade I or II encephalopathy has developed, transfer patients to a transplant center as they may deteriorate rapidly (Table 59.2).



Initial laboratory examination must be extensive and include tests to evaluate for the severity and etiology of the ALF (Table 59.3). Plasma ammonia (venous or arterial), although not very useful in patients with chronic liver disease, can help determine the risk for cerebral herniation in patients with ALF. Although no definite threshold ammonia level has been established, patients with arterial ammonia levels > 200 mcg/dL have a significant risk (close to 100%) of developing severe hepatic encephalopathy and a 55% risk of developing increased intracranial pressure. The utility of a liver biopsy is marginal, as it will usually not change therapy; if indicated, it is typically done via the transjugular approach because of a patient’s coagulopathy.



Hepatic cross-sectional imaging or Doppler ultrasound is important in the diagnosis of ALF. Not only will it look at the hepatic parenchyma and give some information as to the presence of any chronic liver disease (nodular liver, presence of varices, splenomegaly), but it also will look at the patency of the hepatic veins to exclude Budd-Chiari syndrome.


Wilson disease requires special consideration, as it may be difficult to diagnose because the low ceruloplasmin levels that are characteristic of the disease are present in most patients with ALF, regardless of etiology. Kaiser-Fleischer rings are not uniformly present and serum copper levels require several days to obtain. In these cases, a very low alkaline phosphatase with a marked hyperbilirubinemia resulting from profound hemolytic anemia is relatively specific for Wilson disease. An alkaline phosphatase-to-total bilirubin concentration less than 4 is consistent with Wilson disease and may aid in the diagnosis. Rapid diagnosis is essential; these patients will require a liver transplant as spontaneous recovery is estimated at 0%.

< div class='tao-gold-member'>

Jul 7, 2016 | Posted by in CRITICAL CARE | Comments Off on Acute Liver Failure

Full access? Get Clinical Tree

Get Clinical Tree app for offline access